rss
Postgrad Med J 2008;84:172-176 doi:10.1136/pgmj.2008.068205
  • Review

Current and future management of chronic hepatitis C infection

  1. T J S Cross1,
  2. C G Antoniades1,
  3. P M Harrison2
  1. 1
    Institute of Liver Studies, King’s College Hospital, London, UK
  2. 2
    King’s College London School of Medicine, Department of Liver Studies and Transplantation, Division of Gene and Cell-based treatment, London, UK
  1. Dr P Harrison, Department of Liver Studies and Transplantation, Division of Gene and Cell-Based Treatment, King’s College London, Denmark Hill Campus, Bessemer Road, London SE5 9PJ, UK; phillip.Harrison{at}kcl.ac.uk
  • Received 25 January 2008
  • Accepted 29 January 2008

Abstract

Current treatment for patients with chronic hepatitis C virus (HCV) infection consists of the combination of pegylated interferon and ribavirin. This treatment regimen achieves a sustained virological response, defined as undetectable HCV RNA 6 months after treatment cessation, in 50% of patients overall. There is therefore a need for new treatments to improve the sustained virological response rate and reduce the number of adverse effects associated with pegylated interferon and ribavirin. This review examines the current management of chronic HCV infection, including who is eligible for treatment, the optimum duration of treatment, and management of side effects. New drugs in development, such as HCV-specific protease inhibitors, polymerase inhibitors, immune modulators and ribavirin analogues, are outlined, and their role in the treatment armamentarium is discussed, whether used alone or in combination with existing treatments.

Footnotes

  • Competing interests: None declared.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.